Fresh from its first profit, Medcaptain steps into IPO spotlight 业绩扭亏助攻 麦科田生物冲刺港股上市
The maker of medical devices crossed the profit threshold this year thanks to rising demand for its tools to diagnose digestive or urinary problems 在经历多年亏损后，麦科田生物2025年上半年首次实现盈利，反映出公司营运效率提升，以及核心业务的稳健扩张。
Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.